Trained Immunity by Dual-pathway Inhibition in Coronary Artery Disease

Clinical trial NCT05210725 · UNKNOWN

Trial details

NCT number: NCT05210725
Sponsor: Radboud University Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2022-03-01
Primary completion: 2022-04-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.